AQST - Aquestive Therapeutics to join Russell 3000 and Russell 2000 indexes June, 18 2024 08:43 AM Aquestive Therapeutics Inc. 2024-06-18 08:43:02 ET More on Aquestive Therapeutics Aquestive Therapeutics: Positive Phase III Data Unlocks Additional Catalysts For 2024 Aquestive stock falls amid Libervant approval, Anaphylm update Aquestive wins FDA approval for anti-seizure therapy Libervant For further details see: Aquestive Therapeutics to join Russell 3000 and Russell 2000 indexes